Staff & Faculty Directory
Tristen Wright
Assistant Professor; Basic Sciences, College of Osteopathic Medicine
Education Credentials: Ph.D.
Expertise: Cell and Molecular Biology, Cancer Biology
Joined New York Tech: 2026
Tristen Wright, Ph.D., is an assistant professor in the Department of Biomedical and Anatomical Sciences. He earned his B.S. in Biotechnology from Arkansas State University and his Ph.D. in Biomedical Sciences from St. Jude Children’s Research Hospital Graduate School of Biomedical Sciences, where he trained in the Department of Cell and Molecular Biology and studied the molecular regulation of mitochondrial apoptosis by the BCL-2 family of proteins. He subsequently completed postdoctoral training in the Department of Developmental Neurobiology at St. Jude Children’s Research Hospital, where his research focused on the biology of pediatric brain tumors.
Wright’s research focuses on understanding the molecular mechanisms that drive pediatric brain tumors and identifying vulnerabilities that can be exploited for therapeutic development. His laboratory combines cell and molecular biology, cancer biology, protein biochemistry, proteomics, and genetic approaches to investigate how oncogenic proteins alter cellular signaling and survival. He focuses on how dysregulated apoptotic pathways contribute to tumor development and therapeutic resistance in pediatric brain tumors. His research ultimately aims to identify new therapeutic strategies that selectively target tumor cells while minimizing toxicity to the developing brain.
- Fusion oncoprotein biology in pediatric ependymoma: Fusion oncoproteins are defining drivers of pediatric ependymoma. Our research seeks to understand how these fusion oncoproteins alter cellular signaling and protein interactions to promote tumor development and identify vulnerabilities that may be therapeutically targeted.
- Regulation of apoptosis in cancer: Dysregulation of programmed cell death is a fundamental feature of cancer. Our research investigates how alterations in apoptotic signaling allow cancer cells to evade cell death and explores strategies to exploit these vulnerabilities for therapeutic development.
- Regulation of mitochondrial cell death and metabolism: We study the fundamental biology of the BCL-2 family of proteins and their roles in regulating mitochondrial cell death and cellular metabolism. This work seeks to understand how BCL-2 family proteins integrate cellular stress and metabolic signals to control cell survival and death.
- Brakefield-Laird L, Budhraja A, Hall PM, Brewington D, Moore J, Lott J, Ni Y, Voronin D, Grant-Chapman O, Mukiza TO, Wright T, Wang YD, Radko-Juettner S, Pruett-Miller SM, Pounds S, Vogel P, Opferman JT. Mitochondrial integrated stress response activation creates a therapeutic vulnerability to MCL-1 inhibition in acute myeloid leukemia. Cell Death Dis. 2026 Jun 25;17(1). doi: 10.1038/s41419-026-09037-w. PubMed PMID: 42350371; PubMed Central PMCID: PMC13558565.
- Kardian AS, Sun H, Ippagunta S, Laboe N, Varadharajan S, Yu K, Chen HC, Emanus E, Zheng T, Deneen RM, Connelly JP, Wang YD, Zhan J, Liu H, Lowe K, Bugbee T, Pathak R, Bland A, Mehta S, Cochiolo S, Arabzade A, Holcomb B, Budd KM, Kembuan G, Wright T, Caesar E, Park M, Hancock A, Gee D, Murdoch J, Xiao Y, McBrayer SK, Merchant TE, Qi J, Durbin AD, Schwarz LA, Wang L, Donson AM, Foreman NK, Agnihotri S, Lavado A, Baker SJ, Ellison DW, Lee HK, Pruett-Miller SM, Bertrand KC, Deneen B, Mack SC. Dominant clones leverage developmental epigenomic states to drive ependymoma. Nature. 2026 Apr;652(8111):1027–1037. doi: 10.1038/s41586-026-10270-8. Epub 2026 Mar 25. PubMed PMID: 41882368; PubMed Central PMCID: PMC13102692.
- Arabzade A, Shirnekhi HK, Varadharajan S, Ippagunta SM, Phillips AH, Laboe N, Baggett DW, Wahiduzzaman, Jo M, Zheng T, Pathak R, Gee D, Bhimsaria D, Wu H, Gao X, Liu J, Emanus E, Bland A, Kardian A, Hancock A, Holcomb B, Wright T, Bugbee T, Sun H, Zhai M, Caesar E, Park M, Tripathi S, Shirinifard A, Lowe K, Khalighifar A, Petersen RA, King S, Stabley D, Pitre A, Campbell GE, Park CG, Freyaldenhoven WT, Chandra B, Xia Y, Bonten E, Achari A, Kandikonda S, Carisey A, Pounds SB, Xu J, Ellison DW, Deneen B, Bertrand KC, Kriwacki RW, Mack SC. Synthetic ZFTA fusions pinpoint disordered protein domain acquisition as a mechanism of brain tumorigenesis. Nat Cell Biol. 2025 Sep;27(9):1496–1509. doi: 10.1038/s41556-025-01745-3. Epub 2025 Aug 27. PubMed PMID: 40866513; PubMed Central PMCID: PMC12431856.
- Wright T, Turnis ME, Grace CR, Li X, Brakefield LA, Wang YD, Xu H, Kaminska E, Climer LK, Mukiza TO, Chang CL, Moldoveanu T, Opferman JT. Anti-apoptotic MCL-1 promotes long-chain fatty acid oxidation through interaction with ACSL1. Mol Cell. 2024 Apr 4;84(7):1338–1353.e8. doi: 10.1016/j.molcel.2024.02.035. Epub 2024 Mar 18. PubMed PMID: 38503284; PubMed Central PMCID: PMC11017322.
- Alex Lemonade Stand Foundation (ALSF) Young Investigator Grant, 2026
- Top oral presentation (2nd place), St. Jude Graduate School Annual Symposium, 2023
- Student Program Chair, The Society for In Vitro Biology (SIVB) national conference, 2018
- Phillip R. White Award – SIVB national conference, 2018
- Case-based Learning